BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24819656)

  • 1. Antiproliferative and proapoptotic effects of astemizole on cervical cancer cells.
    de Guadalupe Chávez-López M; Hernández-Gallegos E; Vázquez-Sánchez AY; Gariglio P; Camacho J
    Int J Gynecol Cancer; 2014 Jun; 24(5):824-8. PubMed ID: 24819656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astemizole inhibits cell proliferation in human prostate tumorigenic cells expressing ether à-go-go-1 potassium channels.
    Bernal-Ramos G; Hernández-Gallegos E; Vera E; Chávez-López MG; Zúñiga-García V; Sánchez-Pérez Y; Garrido E; Camacho J
    Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):11-13. PubMed ID: 29307346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eag1 Gene and Protein Expression in Human Retinoblastoma Tumors and its Regulation by pRb in HeLa Cells.
    Chávez-López MG; Zúñiga-García V; Castro-Magdonel BE; Vera E; Garrido E; Sánchez-Ramos J; Ponce-Castañeda MV; Cabrera-Muñoz ML; Escobar Y; Ortiz CS; Hernández-Gallegos E; Avalos-Fuentes A; Camacho J
    Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 31973216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
    García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
    PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC.
    de Guadalupe Chávez-López M; Pérez-Carreón JI; Zuñiga-García V; Díaz-Chávez J; Herrera LA; Caro-Sánchez CH; Acuña-Macías I; Gariglio P; Hernández-Gallegos E; Chiliquinga AJ; Camacho J
    Tumour Biol; 2015 Aug; 36(8):6149-58. PubMed ID: 25783527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astemizole: an old anti-histamine as a new promising anti-cancer drug.
    García-Quiroz J; Camacho J
    Anticancer Agents Med Chem; 2011 Mar; 11(3):307-14. PubMed ID: 21443504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitriol down-regulates human ether a go-go 1 potassium channel expression in cervical cancer cells.
    Avila E; García-Becerra R; Rodríguez-Rasgado JA; Díaz L; Ordaz-Rosado D; Zügel U; Steinmeyer A; Barrera D; Halhali A; Larrea F; Camacho J
    Anticancer Res; 2010 Jul; 30(7):2667-72. PubMed ID: 20682996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASTEMIZOLE, AN INHIBITOR OF ETHER-À-GO-GO-1 POTASSIUM CHANNEL, INCREASES THE ACTIVITY OF THE TYROSINE KINASE INHIBITOR GEFITINIB IN BREAST CANCER CELLS.
    García-Quiroz J; González-González ME; Díaz L; Ordaz-Rosado D; Segovia-Mendoza M; Prado-García H; Larrea F; García-Becerra R
    Rev Invest Clin; 2019; 71(3):186-194. PubMed ID: 31184333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.
    Díaz L; Ceja-Ochoa I; Restrepo-Angulo I; Larrea F; Avila-Chávez E; García-Becerra R; Borja-Cacho E; Barrera D; Ahumada E; Gariglio P; Alvarez-Rios E; Ocadiz-Delgado R; Garcia-Villa E; Hernández-Gallegos E; Camacho-Arroyo I; Morales A; Ordaz-Rosado D; García-Latorre E; Escamilla J; Sánchez-Peña LC; Saqui-Salces M; Gamboa-Dominguez A; Vera E; Uribe-Ramírez M; Murbartián J; Ortiz CS; Rivera-Guevara C; De Vizcaya-Ruiz A; Camacho J
    Cancer Res; 2009 Apr; 69(8):3300-7. PubMed ID: 19351862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells.
    García-Becerra R; Díaz L; Camacho J; Barrera D; Ordaz-Rosado D; Morales A; Ortiz CS; Avila E; Bargallo E; Arrecillas M; Halhali A; Larrea F
    Exp Cell Res; 2010 Feb; 316(3):433-42. PubMed ID: 19932096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eag1 potassium channels as markers of cervical dysplasia.
    Ortiz CS; Montante-Montes D; Saqui-Salces M; Hinojosa LM; Gamboa-Dominguez A; Hernández-Gallegos E; Martínez-Benítez B; Del Rosario Solís-Pancoatl M; Garcia-Villa E; Ramírez A; Aguilar-Guadarrama R; Gariglio P; Pardo LA; Stühmer W; Camacho J
    Oncol Rep; 2011 Dec; 26(6):1377-83. PubMed ID: 21887469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrandrine, a novel inhibitor of ether-à-go-go-1 (Eag1), targeted to cervical cancer development.
    Wang X; Chen Y; Li J; Guo S; Lin X; Zhang H; Zhan Y; An H
    J Cell Physiol; 2019 May; 234(5):7161-7173. PubMed ID: 30362536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors.
    García-Quiroz J; García-Becerra R; Santos-Martínez N; Barrera D; Ordaz-Rosado D; Avila E; Halhali A; Villanueva O; Ibarra-Sánchez MJ; Esparza-López J; Gamboa-Domínguez A; Camacho J; Larrea F; Díaz L
    BMC Cancer; 2014 Oct; 14():745. PubMed ID: 25280486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
    Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
    BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological separation of hEAG and hERG K+ channel function in the human mammary carcinoma cell line MCF-7.
    Roy J; Vantol B; Cowley EA; Blay J; Linsdell P
    Oncol Rep; 2008 Jun; 19(6):1511-6. PubMed ID: 18497958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells.
    Horst CH; Titze-de-Almeida R; Titze-de-Almeida SS
    Mol Med Rep; 2017 Apr; 15(4):1479-1488. PubMed ID: 28259991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eag1 channels as potential cancer biomarkers.
    Rodríguez-Rasgado JA; Acuña-Macías I; Camacho J
    Sensors (Basel); 2012; 12(5):5986-95. PubMed ID: 22778627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination astemizole-gefitinib as a potential therapy for human lung cancer.
    Chávez-López MG; Zúñiga-García V; Hernández-Gallegos E; Vera E; Chasiquiza-Anchatuña CA; Viteri-Yánez M; Sanchez-Ramos J; Garrido E; Camacho J
    Onco Targets Ther; 2017; 10():5795-5803. PubMed ID: 29263676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy.
    García-Zepeda SP; García-Villa E; Díaz-Chávez J; Hernández-Pando R; Gariglio P
    Eur J Cancer Prev; 2013 Nov; 22(6):577-84. PubMed ID: 23603746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.